Argi-Jeong (Epinastine Hydrochloride)

Adult dose

1. Asthma, urticaria, eczema/dermatitis, pruritus, prurigo, and common psoriasis accompanied by pruritus Adults: Administer 20 mg of epinastine hydrochloride orally once daily. Adjust the dose as appropriate according to symptoms. 2. Allergic rhinitis Adults: Administer 10～20 mg of this medicine orally once daily. Adjust the dose as appropriate according to symptoms.

This medication should not be used by patients who are allergic to this medication or its ingredients. It contains lactose, so it should not be given to patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. Patients with liver disease or a history of liver disease should use this medication cautiously as liver function may deteriorate. If a rash, urticaria, swelling of the face or limbs, or itching occurs during the use of this medication, it should be discontinued immediately, and a doctor should be consulted. Occasionally, neurological symptoms like drowsiness, headache, dizziness, and insomnia may occur, so caution is needed. Gastrointestinal disturbances such as dyspepsia, nausea, abdominal pain, diarrhea, and constipation may develop, and if symptoms are severe, inform a doctor. Liver function abnormalities may occur, thus liver function tests should be performed regularly, and if abnormalities are detected, the medication should be discontinued. It may affect kidney function, so symptoms related to the kidneys, such as proteinuria, should also be monitored. Rarely, urinary frequency, hematuria, and urinary retention may occur, requiring attention. Symptoms of a rapid heartbeat may occasionally appear, and if such symptoms occur, consult a doctor. Respiratory symptoms like shortness of breath and nasal congestion may rarely occur, so it is advisable to report any abnormalities. Blood-related abnormalities have been reported rarely, so it is important to pay attention to blood test results. This medication is not a fast-acting drug for easing asthma attacks, so it should be adequately explained to asthma patients. Patients receiving long-term steroid treatment should gradually reduce the steroid dose while using this medication, as guided by a physician. This medication may cause drowsiness; therefore, caution is necessary while driving or operating machinery. If there is no effect, avoid long-term use, and it is recommended that seasonal allergy patients start taking it before symptoms appear. The possibility of interactions with other medications is low, but caution is needed when taken with sedatives or alcohol. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of using this medication, and nursing mothers should ideally avoid it or stop breastfeeding. Safety for children or infants has not been sufficiently confirmed, so caution is needed in usage. Elderly patients may have reduced liver and kidney function, so closely monitor for adverse reactions and adjust the dose if necessary. In case of overdose, the risk of cardiac arrhythmias exists, so if symptoms are suspected, seek appropriate medical treatment immediately. This medication should be kept out of reach of children, and it is safer not to transfer it to another container. The timing of administration (before or after meals) can alter the blood concentration of the drug, so it should be used as directed by a physician.

Allergic reactions (rash, hives, redness), itching, swelling (face, extremities, etc.), erythema accompanied by itching, drowsiness, fatigue, headache, dizziness, insomnia, nightmares, numbness, feeling dazed, nausea, gastric discomfort, excessive thirst, abdominal pain, loss of appetite, vomiting, feeling of heaviness in the stomach, feeling of fullness, diarrhea, constipation, dry lips, abdominal distension, stomatitis, liver dysfunction, jaundice, hepatitis, worsening of symptoms, proteinuria, frequent urination, hematuria, urinary retention, palpitations, shortness of breath, difficulty in expectoration, nasal congestion, thrombocytopenia, leukocytosis, gynecomastia, breast enlargement, menstrual abnormalities, flushing, bitter taste, diminished taste, chest pain

This medication should be stored in a tightly closed container to prevent air and moisture from entering. The recommended storage temperature is between 1 degree and 30 degrees Celsius.

Appearance

White or pale yellow round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle